JP Nadda Inaugurates Narayana Health’s First Superspeciality hospital at Gurugram

IMT News Desk
IMT News Desk
· 3 min read
Cdr Navneet Bali (Director – Northern Region, Narayana Health), Dr. Devi Prasad Shetty (Chairman, Executive Director, Narayana Health), Shri J P Nadda, Hon. Union Minister of Health and Family Welfare, Shri Rao Narbir Singh (Hon’ble Minister PWD, Govt. of Haryana) & Dr. Ashutosh Raghuvanshi (Vice Chairman, MD and Group CEO, Narayana Health) at the inauguration of the Narayana Superspeciality Hospital.

Narayana Health, India’s leading healthcare services provider, inaugurated Narayana Superspeciality Hospital, Gurugram – their first hospital in Gurugram, reaffirming their resolve to strengthen the presence in Delhi-NCR region. Narayana Superspeciality Hospital, Gurugram, nestled close to Ambience Mall, DLF Cybercity and Delhi Jaipur Highway, is a multi-speciality hospital with world class medical facilities catering to needs of Delhi-NCR, Haryana, Rajasthan, UP and MP, amongst others.

Shri J P Nadda, Hon. Union Minister of Health and Family Welfare, inaugurated Narayana Superspeciality Hospital, Gurugram, in the presence of Dr Devi Prasad Shetty, Chairman, Executive Director, Narayana Health, Dr Ashutosh Raghuvanshi, Vice Chairman, MD and Group CEO, Narayana Health, along with other esteemed dignitaries including, Shri Rao Narbir Singh, Hon’ble Minister PWD, Govt. of Haryana.

Narayana Superspeciality Hospital, Gurugram, has 211 operational beds with world class intensive care units. The hospital comprises of 6 modular operation theatres with advanced critical care and dialysis units and  has 24×7 Trauma Care & Pharmacy Services and 24×7 Radiology Services ,with  128 Slice CT Scan, 3.0 Tesla MRI. It has two State-of-the-art Cath Labs with Rota and IVUS facilities, and also has fully equipped laboratory medicine and Blood Bank facilities. It is supported by a Well-equipped Physiotherapy & Rehabilitation department and has Round-the-Clock Critical Care Ambulance services.

Dr Ashutosh Raghuvanshi, Vice Chairman, MD and Group CEO, Narayana Health, said, “This is a very proud moment for Narayana Health to launch our first superspeciality hospital in Gurugram. The launch of this hospital in Gurugram is in line with our group’s vision to strengthen our regional presence in Northern India. We have enabled and incorporated every possible stream of clinical speciality here at the heart of Delhi-Gurugram region. Since the hospital is on the national highway, it will also cater to emergency cases 24 X 7. Featuring experienced medical professionals and the latest in medical infrastructure, the hospital represents Narayana Health’s commitment to quality medical care and patient service.”

Narayana Superspeciality Hospital, Gurugram, has been built from the ground-up to be a state-of-the-art facility; with expertly planned and well-equipped sections, including spacious OPD areas and comfortable patient rooms which allows the hospital to cater to both In-Patients and Out-Patients in equal measure. The world-class medical equipment and infrastructure at the hospital ensures that it can provide a wide range of treatments; from complex to routine, and from paediatric to adult, ably supported by a state of art radiology unit with MRI, CT scan and Ultrasound services.

Location-wise the facility has several advantages: It is the closest superspeciality hospital from Indira Gandhi International Airport; It has excellent connectivity via Metro and Highway to Gurugram and Delhi; It is the nearest superspeciality hospital from DLF Cyber City; and it is close to major residential areas in Gurugram.

The hospital has a cafeteria and provides accommodation facilities for patient visitors and care givers who may be required to stay at the premises till the patient’s recovery process.

Apart from treatment and regular medical processes, the hospital will also provide regular preventive healthcare facilities, medical check-ups and awareness camps from time to time for the residents of Gurugram.

Narayana Superspeciality Hospital, Gurugram has more than 30 streams of clinical specialities of which Cardiac Sciences, Orthopaedics, Neurosciences, Nephrology, Urology, Gastroenterology and Oncology, will be centres of excellence offering tertiary care services with 24-hour laboratory, critical care and emergency.

Read Next

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management
Corporate
January 27, 2026

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management

Company to launch product after the expiry of semaglutide patent in India Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct to […]
Article by: IMT News Desk
Lupin receives highest ESG rating from CDP for climate change and water security
Corporate
January 27, 2026

Lupin receives highest ESG rating from CDP for climate change and water security

The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency at the highest level Lupin has received the highest ‘A’ leadership rating from Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency […]
Article by: IMT News Desk
AstraZeneca Pharma India receives CDSCO approval for breast cancer drug
Corporate
December 19, 2025

AstraZeneca Pharma India receives CDSCO approval for breast cancer drug

Dato-DXd is a specifically engineered antibody drug conjugate that targets TROP2, a protein frequently overexpressed in breast cancer AstraZeneca Pharma India announced that the Central Drugs Standard Control Organisation (CDSCO) has granted regulatory approval to import, sell, and distribute Datopotamab Deruxtecan (Dato-DXd) in India. The approval reflects AstraZeneca’s focus on bringing to life-changing medicines at […]
Article by: IMT News Desk
Novo Nordisk launches Ozempic in India
Corporate
December 12, 2025

Novo Nordisk launches Ozempic in India

Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living with uncontrolled type 2 diabetes mellitus Novo Nordisk announced the launch of Ozempic (injectable semaglutide) in India. Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living […]
Article by: IMT News Desk